Reportlinker.com

Reportlinker.com

June 24, 2008 14:18 ET

High Growth Forecasted for the World Specialty Enzymes Market

LONDON, UNITED KINGDOM--(Marketwire - June 24, 2008) - Reportlinker.com announces that a new market research report related to the Chemicals industry industry is available in its catalogue.

World Specialty Enzymes Market

http://www.reportlinker.com/p090599/World-Specialty-Enzymes-Market.html

This report analyzes the worldwide markets for Specialty Enzymes in Millions of US$. The specific product segments analyzed are Specialty Medical Enzymes, Polymerases, Nucleases, and Other Specialty Enzymes. The specific end-use segments discussed are Pharmaceuticals & Diagnostics, and Research/Biotechnology. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 44 companies including many key and niche players worldwide such as Advanced Enzymes Technologies Limited, Amano Enzyme Inc., Aureozyme Inc., Biocon Ltd., Operational Model of Biocon, Biozyme Laboratories, Danisco, Genencor, Kinetic Biosystems, Inc., Maxygen Inc, Codexis Inc., Novozymes, Seravac Biotech (Pty) Ltd, Specialty Enzymes and Biochemicals Co., and Verenium Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

SPECIALTY ENZYMES MCP-2056

A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability And Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-2

Quantitative Techniques & Analytics I-2

Product Definitions And Scope Of Study I-3

Specialty Medical Enzymes I-3

Polymerases I-3

Nucleases I-4

Other Specialty Enzymes I-4

Pharmaceuticals/Diagnostic I-4

Research/Biotechnology I-4

II. EXECUTIVE SUMMARY

1. Introduction II-1

2. Global Market Overview II-2

3. Enzymes- A Review II-3

Definition II-3

Introduction II-3

Advantages of Enzymes Compared to Chemical Catalysts II-3

Table 1: Enzymes Market Worldwide (2005 & 2006): Market Share

of Leading Players- Novozymes, Genencol, DSM, BASF and Others

(includes corresponding Graph/Chart) II-4

A Brief History II-4

4. Specialty Enzymes: An Overview II-6

Analysis of Product Segments II-6

Specialty Medical Enzymes II-6

Polymerases II-7

Nucleases II-7

Other Specialty Enzymes II-7

5. Analysis of the End-Use Markets II-8

Pharmaceuticals & Diagnostics II-8

Research/Biotechnology II-8

Other End Use Markets II-8

6. Technology Trends II-9

Protein Engineering Technology II-9

Specialty Enzymes in Industrial Uses II-9

Enzyme Technology in Pig Industry II-9

7. Product Innovations/Introductions II-10

MARDI Develops Taq DNA Polymerase II-10

Stratagene Corporation Commercializes DNA Polymerases II-10

Takara Bio Launches PrimeSTAR HS DNA Polymerase II-10

Verdia and Pioneer Hi-Bred International Develops Glyphosate

-Resistant Crop Trait II-10

Novozymes Creates Lipase Enzyme II-10

8. Recent Industry Activity II-11

Inverness Medical Innovations Acquires BBI Holdings Plc II-11

Helix Biopharma Enters into a Contract with KBI Biopharma II-11

Verenium Enters into Agreement with Bunge Oils II-11

BBI Holdings Acquires Theratase Plc II-11

Danisco to Acquire Stake in South African Firm II-11

Affymetrix to Buy USB Corporation II-12

Diversa Merges with Celunol to Form Verenium Corporation II-12

Diversa Collaborates with BASF II-12

Codexis Expands Collaboration with Royal Dutch Shell to

Develop Super Enzymes II-12

Diversa Enters into a Deal with Syngenta to Develop Enzymes II-12

Genencor Begins Operation at New China Site and Introduces a

New Detergent Enzyme II-12

Verenium Receives $4.6 million For Enzyme Development II-13

Biocon Divests its Enzymes Business to Novozymes II-13

Solexa Signs Agreement with New England Biolabs II-13

Danisco Takes Over Genencor II-13

IBEX Technologies Inks Agreement with Cape Cod and Prozyme II-13

9. Focus on Select Players Worldwide II-14

Advanced Enzymes Technologies Limited (India) II-14

Amano Enzyme Inc. (Japan) II-14

Aureozyme Inc. (USA) II-14

Biocon Ltd. (India) II-15

Operational Model of Biocon II-15

Biozyme Laboratories (UK) II-15

Danisco (Denmark) II-16

Genencor (USA) II-16

Kinetic Biosystems, Inc. (USA) II-17

Maxygen Inc (USA) II-17

Codexis Inc. (USA) II-17

Novozymes (Denmark) II-17

Seravac Biotech (Pty) Ltd (South Africa) II-18

Specialty Enzymes and Biochemicals Co. (USA) II-18

Verenium Corporation (USA) II-18

10. Global Market Perspective II-19

Table 2: World Recent Past, Current & Future Analysis for

Specialty Enzymes by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Middle East, and

Latin America Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2000 through 2010 (includes

corresponding Graph/Chart) II-19

Table 3: World Long-term Projections for Specialty Enzymes by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Middle East, and Latin America Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2011 through 2015 (includes corresponding

Graph/Chart) II-20

Table 4: World 10-Year Perspective for Specialty Enzymes by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Middle East, and Latin America Markets for Years 2003, 2008 &

2012 (includes corresponding Graph/Chart) II-21

Table 5: World Recent Past, Current & Future Analysis for

Specialty Medical Enzymes by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Middle East,

and Latin America Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2000 through 2010

(includes corresponding Graph/Chart) II-22

Table 6: World Long-term Projections for Specialty Medical

Enzymes by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Middle East, and Latin America

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2011 through 2015 (includes

corresponding Graph/Chart) II-23

Table 7: World 10-Year Perspective for Specialty Medical

Enzymes by Geographic Region - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Middle East, and Latin America Markets for Years 2003,

2008 & 2012 (includes corresponding Graph/Chart) II-24

Table 8: World Recent Past, Current & Future Analysis for

Polymerases by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Middle East, and Latin

America Markets Independently Analyzed with Annual Sales

Figuresin US$ Million for Years 2000 through 2010 (includes

corresponding Graph/Chart) II-25

Table 9: World Long-term Projections for Polymerases by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Middle East, and Latin America Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2011 through 2015 (includes corresponding

Graph/Chart) II-26

Table 10: World 10-Year Perspective for Polymerases by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Middle East, and Latin America Markets for Years 2003, 2008 &

2012 (includes corresponding Graph/Chart) II-27

Table 11: World Recent Past, Current & Future Analysis for

Nucleases by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Middle East, and Latin America

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2000 through 2010 (includes

corresponding Graph/Chart) II-28

Table 12: World Long-term Projections for Nucleases by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Middle East, and Latin America Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2011 through 2015 (includes corresponding

Graph/Chart) II-29

Table 13: World 10-Year Perspective for Nucleases by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Middle East, and Latin America Markets for Years 2003, 2008 &

2012 (includes corresponding Graph/Chart) II-30

Table 14: World Recent Past, Current & Future Analysis for

Other Specialty Enzymes by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Middle East,

and Latin America Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2000 through 2010

(includes corresponding Graph/Chart) II-31

Table 15: World Long-term Projections for Other Specialty

Enzymes by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Middle East, and Latin America

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2011 through 2015 (includes

corresponding Graph/Chart) II-32

Table 16: World 10-Year Perspective for Other Specialty

Enzymes by Geographic Region - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Middle East, and Latin America Markets for Years 2003,

2008 & 2012 (includes corresponding Graph/Chart) II-33

Table 17: World Recent Past, Current & Future Analysis for

Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics

by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Middle East, and Latin America Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes corresponding

Graph/Chart) II-34

Table 18: World Long-term Projections for Specialty Enzymes

Consumption in Pharmaceuticals & Diagnostics by Geographic

Region- US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Middle East, and Latin America Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2011 through 2015 (includes corresponding Graph/Chart) II-35

Table 19: World 10-Year Perspective for Specialty Enzymes

Consumption in Pharmaceuticals & Diagnostics by Geographic

Region - Percentage Breakdown of Dollar Sales for US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Middle East,

and Latin America Markets for Years 2003, 2008 & 2012

(includes corresponding Graph/Chart) II-36

Table 20: World Recent Past, Current & Future Analysis for

Specialty Enzymes Consumption in Research/Biotechnology by

Geographic Region- US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Middle East, and Latin America Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes corresponding

Graph/Chart) II-37

Table 21: World Long-term Projections for Specialty Enzymes

Consumption in Research/Biotechnology by Geographic Region-

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Middle East, and Latin America Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2011

through 2015 (includes corresponding Graph/Chart) II-38

Table 22: World 10-Year Perspective for Specialty Enzymes

Consumption in Research/Biotechnology by Geographic Region -

Percentage Breakdown of Dollar Sales for US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Middle East, and

Latin America Markets for Years 2003, 2008 & 2012 (includes

corresponding Graph/Chart) II-39

Table 23: World Recent Past, Current & Future Analysis for

Specialty Enzymes Consumption in Other End-Use Segments by

Geographic Region- US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Middle East, and Latin America Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes corresponding

Graph/Chart) II-40

Table 24: World Long-term Projections for Specialty Enzymes

Consumption in Other End-Use Segments by Geographic Region-

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Middle East, and Latin America Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2011

through 2015 (includes corresponding Graph/Chart) II-41

Table 25: World 10-Year Perspective for Specialty Enzymes

Consumption in Other End-Use Segments by Geographic Region -

Percentage Breakdown of Dollar Sales for US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Middle East, and Latin

America Markets for Years 2003, 2008 & 2012 (includes

corresponding Graph/Chart) II-42

III. MARKET

1. The United States III-1

A.Market Analysis III-1

Market Dynamics III-1

Specialty Enzymes Market is Projected to Rise 7% Annually III-1

Specialty Enzymes Form the Leading Enzymes Segment III-1

Pharmaceuticals and Diagnostics Continue to be the Largest

Market III-1

Specialty Medical Enzymes in a Myriad of Novel Applications III-2

Market for Enzymes in Biotechnology III-2

Product Launch III-2

Strategic Corporate Developments III-2

Select Players III-4

Aureozyme Inc. III-4

Genencor. III-5

Kinetic Biosystems, Inc. III-5

Maxygen Inc III-5

Codexis Inc. III-6

Specialty Enzymes and Biochemicals Co. III-6

Verenium Corporation III-6

B.Market Analytics III-7

Table 26: US Recent Past, Current & Future Analysis for

Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes corresponding

Graph/Chart) III-7

Table 27: US Long-term Projections for Specialty Enzymes by

Product Segment - Specialty Medical Enzymes, Polymerases,

Nucleases and Other Enzymes Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2011

through 2015 (includes corresponding Graph/Chart) III-7

Table 28: US 10-Year Perspective for Specialty Enzymes by

Product Segment - Percentage Breakdown of Dollar Sales for

Specialty Medical Enzymes, Polymerases, Nucleases and Other

Enzymes Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-8

Table 29: US Recent Past, Current & Future Analysis for

Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research/Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes

corresponding Graph/Chart) III-9

Table 30: US Long-term Projections for Specialty Enzymes by

End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2011 through 2015 (includes corresponding Graph/Chart) III-9

Table 31: US 10-Year Perspective for Specialty Enzymes by

End-Use Segment - Percentage Breakdown of Dollar Sales for

Pharmaceuticals & Diagnostics, Research/Biotechnology and

Others Markets for 2003, 2008 & 2012 (includes corresponding

Graph/Chart) III-10

2. Canada III-11

A.Market Analysis III-11

Strategic Corporate Development III-11

B.Market Analytics III-11

Table 32: Canadian Recent Past, Current & Future Analysis

for Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010(includes corresponding

Graph/Chart) III-11

Table 33: Canadian Long-term Projections for Specialty

Enzymes by Product Segment - Specialty Medical Enzymes,

Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2011 through 2015 (includes corresponding

Graph/Chart) III-12

Table 34: Canadian 10-Year Perspective for Specialty Enzymes

by Product Segment - Percentage Breakdown of Dollar Sales

for Specialty Medical Enzymes, Polymerases, Nucleases and

Other Enzymes Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-12

Table 35: Canadian Recent Past, Current & Future Analysis

for Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research / Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes corresponding

Graph/Chart) III-13

Table 36: Canadian Long-term Projections for Specialty

Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2011 through 2015 (includes corresponding Graph/Chart) III-13

Table 37: Canadian 10-Year Perspective for Specialty Enzymes

by End-Use Segment - Percentage Breakdown of Dollar Sales

for Pharmaceuticals & Diagnostics, Research/ Biotechnology

and Others Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-14

3. Japan III-15

A.Market Analysis III-15

Product Launch III-15

Amano Enzyme Inc. - A Major Player III-15

B.Market Analytics III-16

Table 38: Japanese Recent Past, Current & Future Analysis

for Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes

corresponding Graph/Chart) III-16

Table 39: Japanese Long-term Projections for Specialty

Enzymes by Product Segment - Specialty Medical Enzymes,

Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2011 through 2015 (includes corresponding

Graph/Chart) III-17

Table 40: Japanese 10-Year Perspective for Specialty Enzymes

by Product Segment - Percentage Breakdown of Dollar Sales

for Specialty Medical Enzymes, Polymerases, Nucleases and

Other Enzymes Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-17

Table 41: Japanese Recent Past, Current & Future Analysis

for Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research/Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes corresponding

Graph/Chart) III-18

Table 42: Japanese Long-term Projections for Specialty

Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2011 through 2015 (includes corresponding Graph/Chart) III-18

Table 43: Japanese 10-Year Perspective for Specialty Enzymes

by End-Use Segment - Percentage Breakdown of Dollar Sales

for Pharmaceuticals & Diagnostics, Research / Biotechnology

and Others Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-19

4. Europe III-20

Market Analysis III-20

Table 44: European Recent Past, Current & Future Analysis

for Specialty Enzymes by Geographic Region - France,

Germany, Italy, UK, Spain, Russia, and Rest of Europe

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2000 through 2010 (includes

corresponding Graph/Chart) III-20

Table 45: European Long-term Projections for Specialty

Enzymes by Geographic Region - France, Germany, Italy, UK,

Spain, Russia, and Rest of Europe Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2011 through 2015 (includes corresponding Graph/Chart) III-21

Table 46: European 10-Year Perspective for Specialty Enzymes

by Geographic Region - Percentage Breakdown of Dollar Sales

for France, Germany, Italy, UK, Spain, Russia, and Rest of

Europe Markets for Years 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-22

Table 47: European Recent Past, Current & Future Analysis

for Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes

corresponding Graph/Chart) III-23

Table 48: European Long-term Projections for Specialty

Enzymes by Product Segment - Specialty Medical Enzymes,

Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2011 through 2015 (includes corresponding

Graph/Chart) III-23

Table 49: European 10-Year Perspective for Specialty Enzymes

by Product Segment - Percentage Breakdown of Dollar Sales

for Specialty Medical Enzymes Polymerases, Nucleases and

Other Enzymes Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-24

Table 50: European Recent Past, Current & Future Analysis

for Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research/Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes corresponding

Graph/Chart) III-25

Table 51: European Long-term Projections for Specialty

Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2011 through 2015 (includes corresponding Graph/Chart) III-25

Table 52: European 10-Year Perspective for Specialty Enzymes

by End-Use Segment - Percentage Breakdown of Dollar Sales

for Pharmaceuticals & Diagnostics, Research/ Biotechnology

and Others Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-26

4a. France III-27

Market Analysis III-27

Table 53: French Recent Past, Current & Future Analysis for

Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes corresponding

Graph/Chart) III-27

Table 54: French Long-term Projections for Specialty Enzymes

by Product Segment - Specialty Medical Enzymes, Polymerases,

Nucleases and Other Enzymes Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2011

through 2015 (includes corresponding Graph/Chart) III-28

Table 55: French 10-Year Perspective for Specialty Enzymes

by Product Segment - Percentage Breakdown of Dollar Sales

for Specialty Medical Enzymes, Polymerases, Nucleases and

Other Enzymes Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-28

Table 56: French Recent Past, Current & Future Analysis for

Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research/Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes corresponding

Graph/Chart) III-29

Table 57: French Long-term Projections for Specialty Enzymes

by End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2011 through 2015 (includes corresponding Graph/Chart) III-29

Table 58: French 10-Year Perspective for Specialty Enzymes

by End-Use Segment - Percentage Breakdown of Dollar Sales

for Pharmaceuticals & Diagnostics, Research/ Biotechnology

and Others Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-30

4b. Germany III-31

Market Analysis III-31

Table 59: German Recent Past, Current & Future Analysis for

Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes corresponding

Graph/Chart) III-31

Table 60: German Long-term Projections for Specialty Enzymes

by Product Segment - Specialty Medical Enzymes, Polymerases,

Nucleases and Other Enzymes Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2011

through 2015 (includes corresponding Graph/Chart) III-32

Table 61: German 10-Year Perspective for Specialty Enzymes

by Product Segment - Percentage Breakdown of Dollar Sales

for Specialty Medical Enzymes, Polymerases, Nucleases and

Other Enzymes Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-32

Table 62: German Recent Past, Current & Future Analysis for

Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research/Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes corresponding

Graph/Chart) III-33

Table 63: German Long-term Projections for Specialty Enzymes

by End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2011 through 2015 (includes corresponding Graph/Chart) III-33

Table 64: German 10-Year Perspective for Specialty Enzymes

by End-Use Segment - Percentage Breakdown of Dollar Sales

for Pharmaceuticals & Diagnostics, Research/ Biotechnology

and Others Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-34

4c. Italy III-35

Market Analysis III-35

Table 65: Italian Recent Past, Current & Future Analysis for

Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes corresponding

Graph/Chart) III-35

Table 66: Italian Long-term Projections for Specialty

Enzymes by Product Segment - Specialty Medical Enzymes,

Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2011 through 2015 (includes corresponding

Graph/Chart) III-36

Table 67: Italian 10-Year Perspective for Specialty Enzymes

by Product Segment - Percentage Breakdown of Dollar Sales

for Specialty Medical Enzymes, Polymerases, Nucleases and

Other Enzymes Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-36

Table 68: Italian Recent Past, Current & Future Analysis for

Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research/Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes

corresponding Graph/Chart) III-37

Table 69: Italian Long-term Projections for Specialty

Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2011 through 2015 (includes corresponding Graph/Chart) III-37

Table 70: Italian 10-Year Perspective for Specialty Enzymes

by End-Use Segment - Percentage Breakdown of Dollar Sales

for Pharmaceuticals & Diagnostics, Research/ Biotechnology

and Others Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-38

4d. The United Kingdom III-39

A.Market Analysis III-39

Biozyme Laboratories Limited - A Major Player III-39

B.Market Analytics III-40

Table 71: UK Recent Past, Current & Future Analysis for

Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes corresponding

Graph/Chart) III-40

Table 72: UK Long-term Projections for Specialty Enzymes by

Product Segment - Specialty Medical Enzymes, Polymerases,

Nucleases and Other Enzymes Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2011

through 2015 (includes corresponding Graph/Chart) III-41

Table 73: UK 10-Year Perspective for Specialty Enzymes by

Product Segment - Percentage Breakdown of Dollar Sales for

Specialty Medical Enzymes, Polymerases, Nucleases and Other

Enzymes Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-41

Table 74: UK Recent Past, Current & Future Analysis for

Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research/Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes corresponding

Graph/Chart) III-42

Table 75: UK Long-term Projections for Specialty Enzymes by

End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2011 through 2015 (includes corresponding Graph/Chart) III-42

Table 76: UK 10-Year Perspective for Specialty Enzymes by

End-Use Segment - Percentage Breakdown of Dollar Sales for

Pharmaceuticals & Diagnostics, Research/ Biotechnology and

Others Markets for 2003, 2008 & 2012 (includes corresponding

Graph/Chart) III-43

4e. Spain III-44

Market Analysis III-44

Table 77: Spanish Recent Past, Current & Future Analysis for

Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes corresponding

Graph/Chart) III-44

Table 78: Spanish Long-term Projections for Specialty

Enzymes by Product Segment - Specialty Medical Enzymes,

Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2011 through 2015 (includes corresponding

Graph/Chart) III-45

Table 79: Spanish 10-Year Perspective for Specialty Enzymes

by Product Segment - Percentage Breakdown of Dollar Sales

for Specialty Medical Enzymes, Polymerases, Nucleases and

Other Enzymes Markets for 2003, 2008 & 2012(includes

corresponding Graph/Chart) III-45

Table 80: Spanish Recent Past, Current & Future Analysis for

Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research/Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010(includes corresponding

Graph/Chart) III-46

Table 81: Spanish Long-term Projections for Specialty

Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2011 through 2015 (includes corresponding Graph/Chart) III-46

Table 82: Spanish 10-Year Perspective for Specialty Enzymes

by End-Use Segment - Percentage Breakdown of Dollar Sales

for Pharmaceuticals & Diagnostics, Research/ Biotechnology

and Others Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-47

4f. Russia III-48

Market Analysis III-48

Table 83: Russian Recent Past, Current & Future Analysis for

Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes corresponding

Graph/Chart) III-48

Table 84: Russian Long-term Projections for Specialty

Enzymes by Product Segment - Specialty Medical Enzymes,

Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2011 through 2015 (includes corresponding

Graph/Chart) III-49

Table 85: Russian 10-Year Perspective for Specialty Enzymes

by Product Segment - Percentage Breakdown of Dollar Sales

for Specialty Medical Enzymes, Polymerases, Nucleases and

Other Enzymes Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-49

Table 86: Russian Recent Past, Current & Future Analysis for

Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research/Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2010 (includes corresponding

Graph/Chart) III-50

Table 87: Russian Long-term Projections for Specialty

Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2011 through 2015 (includes corresponding Graph/Chart) III-50

Table 88: Russian 10-Year Perspective for Specialty Enzymes

by End-Use Segment - Percentage Breakdown of Dollar Sales

for Pharmaceuticals & Diagnostics, Research / Biotechnology

and Others Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-51

4g. Rest of Europe III-52

A.Market Analysis III-52

Strategic Corporate Development III-52

Select Players III-52

Danisco (Denmark) III-52

Novozymes (Denmark) III-53

B.Market Analytics III-54

Table 89: Rest of Europe Recent Past, Current & Future

Analysis for Specialty Enzymes by Product Segment -

Specialty Medical Enzymes, Polymerases, Nucleases and Other

Enzymes Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2000 through 2010

(includes corresponding Graph/Chart) III-54

Table 90: Rest of Europe Long-term Projections for Specialty

Enzymes by Product Segment - Specialty Medical Enzymes,

Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2011 through 2015 (includes corresponding

Graph/Chart) III-55

Table 91: Rest of Europe 10-Year Perspective for Specialty

Enzymes by Product Segment - Percentage Breakdown of Dollar

Sales for Specialty Medical Enzymes, Polymerases, Nucleases

and Other Enzymes Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-56

Table 92: Rest of Europe Recent Past, Current & Future

Analysis for Specialty Enzymes by End-Use Segment -

Pharmaceuticals & Diagnostics, Research / Biotechnology and

Others Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2000 through 2010 (includes

corresponding Graph/Chart) III-57

Table 93: Rest of Europe Long-term Projections for Specialty

Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,

Research / Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2011 through 2015 (includes corresponding Graph/Chart) III-57

Table 94: Rest of Europe 10-Year Perspective for Specialty

Enzymes by End-Use Segment - Percentage Breakdown of Dollar

Sales for Pharmaceuticals & Diagnostics, Research/

Biotechnology and Others Markets for 2003, 2008 & 2012

(includes corresponding Graph/Chart) III-58

5. Asia-Pacific III-59

A.Market Analysis III-59

Enzyme Market in China III-59

Product Launch III-59

Strategic Corporate Development III-60

Select Players III-60

Advanced Enzymes Technologies Limited (India) III-60

Biocon Ltd. (India) III-60

B.Market Analytics III-62

Table 95: Asia-Pacific Recent Past, Current & Future

Analysis for Specialty Enzymes by Product Segment -

Specialty Medical Enzymes, Polymerases, Nucleases and Other

Enzymes Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2000 through 2010 (includes

corresponding Graph/Chart) III-62

Table 96: Asia-Pacific Long-term Projections for Specialty

Enzymes by Product Segment - Specialty Medical Enzymes,

Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2011 through 2015 (includes corresponding

Graph/Chart) III-63

Table 97: Asia-Pacific 10-Year Perspective for Specialty

Enzymes by Product Segment - Percentage Breakdown of Dollar

Sales for Specialty Medical Enzymes, Polymerases, Nucleases

and Other Enzymes Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-64

Table 98: Asia-Pacific Recent Past, Current & Future

Analysis for Specialty Enzymes by End-Use Segment -

Pharmaceuticals & Diagnostics, Research / Biotechnology and

Others Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2000 through 2010 (includes

corresponding Graph/Chart) III-65

Table 99: Asia-Pacific Long-term Projections for Specialty

Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,

Research / Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2011 through 2015 (includes corresponding Graph/Chart) III-65

Table 100: Asia-Pacific 10-Year Perspective for Specialty

Enzymes by End-Use Segment - Percentage Breakdown of Dollar

Sales for Pharmaceuticals & Diagnostics, Research/

Biotechnology and Others Markets for 2003, 2008 & 2012

(includes corresponding Graph/Chart) III-66

6. The Middle East III-67

Market Analysis III-67

Table 101: Middle East Recent Past, Current & Future

Analysis for Specialty Enzymes by Product Segment -

Specialty Medical Enzymes, Polymerases, Nucleases and Other

Enzymes Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2000 through 2010 (includes

corresponding Graph/Chart) III-67

Table 102: Middle East Long-term Projections for Specialty

Enzymes by Product Segment - Specialty Medical Enzymes,

Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2011 through 2015 (includes corresponding

Graph/Chart) III-68

Table 103: Middle East 10-Year Perspective for Specialty

Enzymes by Product Segment - Percentage Breakdown of Dollar

Sales for Specialty Medical Enzymes, Polymerases, Nucleases

and Other Enzymes Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-68

Table 104: Middle East Recent Past, Current & Future

Analysis for Specialty Enzymes by End-Use Segment -

Pharmaceuticals & Diagnostics, Research/Biotechnology and

Others Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2000 through 2010(includes

corresponding Graph/Chart) III-69

Table 105: Middle East Long-term Projections for Specialty

Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,

Research/Biotechnology and Others Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2011 through 2015 (includes corresponding Graph/Chart) III-69

Table 106: Middle East 10-Year Perspective for Specialty

Enzymes by End-Use Segment - Percentage Breakdown of Dollar

Sales for Pharmaceuticals & Diagnostics, Research/

Biotechnology and Others Markets for 2003, 2008 & 2012

(includes corresponding Graph/Chart) III-70

7. Latin America III-71

Market Analysis III-71

Table 107: Latin American Recent Past, Current & Future

Analysis for Specialty Enzymes by Product Segment -

Specialty Medical Enzymes, Polymerases, Nucleases and Other

Enzymes Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2000 through 2010 (includes

corresponding Graph/Chart) III-71

Table 108: Latin American Long-term Projections for

Specialty Enzymes by Product Segment - Specialty Medical

Enzymes, Polymerases, Nucleases and Other Enzymes Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2011 through 2015 (includes corresponding

Graph/Chart) III-72

Table 109: Latin American 10-Year Perspective for Specialty

Enzymes by Product Segment - Percentage Breakdown of Dollar

Sales for Specialty Medical Enzymes, Polymerases, Nucleases

and Other Enzymes Markets for 2003, 2008 & 2012 (includes

corresponding Graph/Chart) III-72

Table 110: Latin American Recent Past, Current & Future

Analysis for Specialty Enzymes by End-Use Segment -

Pharmaceuticals & Diagnostics, Research/ Biotechnology and

Others Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2000 through 2010 (includes

corresponding Graph/Chart) III-73

Table 111: Latin American Long-term Projections for

Specialty Enzymes by End-Use Segment - Pharmaceuticals &

Diagnostics, Research/Biotechnology and Others Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2011 through 2015 (includes corresponding

Graph/Chart) III-73

Table 112: Latin American 10-Year Perspective for Specialty

Enzymes by End-Use Segment - Percentage Breakdown of Dollar

Sales for Pharmaceuticals & Diagnostics, Research/

Biotechnology and Others Markets for 2003, 2008 & 2012

(includes corresponding Graph/Chart) III-74

IV. COMPETITIVE LANDSCAPE

To order this report:

World Specialty Enzymes Market

http://www.reportlinker.com/p090599/World-Specialty-Enzymes-Market.html

More market research reports here!

Contact Information